Neola Medical (NEOLA.ST) Stock Price
Neola Medical Price
Revenue at Neola Medical has contracted by 22.5% per year over the past 5 years to 625,000.00 SEK. Neola Medical's net margin stands at -1,064.5%, down from -102.0% several years earlier.
Neola Medical stock price
Neola Medical business model & stock analysis
Frequently asked questions about Neola Medical
Converted at the current exchange rate, the Neola Medical share trades at 0.04 EUR (0.45 SEK).
The expected revenue of Neola Medical is 12.10 M SEK. This figure is based on current financial data and reflects the company's business performance.
The expected profit of Neola Medical is -15.59 M SEK. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Neola Medical is currently -2.27. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Neola Medical stock.
The price-to-sales ratio (P/S) of Neola Medical is currently 2.92. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Neola Medical stock.
The Eulerpool Quality Score for Neola Medical is 2/10.
The ISIN of Neola Medical is SE0014829255. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Neola Medical is NEOLA.ST. The ticker symbol is used to trade Neola Medical shares on the stock exchange.
Neola Medical stock
Neola Medical Peer Group
Neola Medical FIGI
All fundamentals and in-depth analysis of Neola Medical
Our stock analysis for Neola Medical stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Neola Medical. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.